Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1.
about
Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAFVitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells.A Microbial Feed Additive Abates Intestinal Inflammation in Atlantic SalmonImmunotherapeutic restoration in HIV-infected individuals.shRNA-mediated downregulation of α-N-Acetylgalactosaminidase inhibits migration and invasion of cancer cell lines.Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).Multiple exo-glycosidases in human serum as detected with the substrate DNP-α-GalNAc. II. Three α-N-acetylgalactosaminidase-like activities in the pH 5 to 8 region.Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.The Effect of Fucoidan from the Brown Alga Fucus evanescence on the Activity of α-N-Acetylgalactosaminidase of Human Colon Carcinoma Cells.
P2860
Q24645388-30A6007A-AB2B-4568-B327-7E275F97258BQ33728338-CD3AC040-FB92-4224-83F9-EF6237AA0D8AQ35969999-72BCCB13-CC3C-4CA8-ACFB-EEC911866567Q37842335-9D750F92-7654-4EE2-B17B-B4E55666BCB1Q45873773-482B5545-7B81-41F3-B1E4-32D539624B5DQ46952255-C1697935-F706-4017-AB1E-0DE18762BAAFQ47133246-0A5C0CCD-7DD9-44FE-B090-28B2E0C15675Q51110849-965FB684-5B1C-476C-978A-975095B06338Q55332943-96C130EB-794B-4E80-A9A5-0D9F7CA0D014
P2860
Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Pathogenic significance of alp ...... immunodeficiency virus Type 1.
@en
Pathogenic significance of alp ...... immunodeficiency virus Type 1.
@nl
type
label
Pathogenic significance of alp ...... immunodeficiency virus Type 1.
@en
Pathogenic significance of alp ...... immunodeficiency virus Type 1.
@nl
prefLabel
Pathogenic significance of alp ...... immunodeficiency virus Type 1.
@en
Pathogenic significance of alp ...... immunodeficiency virus Type 1.
@nl
P356
P1476
Pathogenic significance of alp ...... immunodeficiency virus Type 1.
@en
P2093
Nobuto Yamamoto
P304
P356
10.1089/AID.2006.22.262
P577
2006-03-01T00:00:00Z